Insider · CIK 0001569225
Jeff Castelli
Files at FOLD (AMICUS THERAPEUTICS, INC.). First filing Dec 20, 2023, latest Nov 26, 2025.
In brief
Jeff Castelli files SEC Form 4 as officer at FOLD (AMICUS THERAPEUTICS, INC.). Since Dec 20, 2023, Jeff Castelli has reported 0 open-market buys worth $0 and 3 open-market sells worth $1.3M, the latest filed on Nov 26, 2025.
A track record needs three past buys with six months of prices behind them; Jeff Castelli has 0, so none is measured yet.
The newest scored trade: sold $774k of FOLD on Nov 24, 2025, filed Nov 26, 2025, scored 22 (weak), under a 10b5-1 plan. In the last 12 months: 0 buys worth $0 and 1 sell worth $774k.
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 22Weak | AMICUS THERAPEUTICS, INC. | $774k 76,158 shares | -15% | - | |
| 23Weak | AMICUS THERAPEUTICS, INC. | $253k 17,421 shares | -5% | - | |
| 23Weak | AMICUS THERAPEUTICS, INC. | $254k 19,154 shares | -5% | - |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Nov 24, 2025 | FOLD AMICUS THERAPEUTICS INC | 76,158 0.02% of outstanding | $728k | Nov 24, 2025 | none |
| Dec 28, 2023 | FOLD AMICUS THERAPEUTICS INC | 1,575 0.00% of outstanding | $23k | Dec 28, 2023 | $254k |
| Dec 20, 2023 | FOLD AMICUS THERAPEUTICS INC | 17,500 0.01% of outstanding | $231k | Dec 20, 2023 | $232k |
| Dec 19, 2023 | FOLD AMICUS THERAPEUTICS INC | 17,500 0.01% of outstanding | $222k | Dec 19, 2023 | none |
Transactions
Every row this insider has filed, 23 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Apr 27, 2026 | FOLD AMICUS THERAPEUTICS, INC. | DDisposition to issuer Common Stock | -427,089 | $14.50 | $6.2M | 0 | Apr 27, 2026 |
| Apr 27, 2026 | FOLD AMICUS THERAPEUTICS, INC. | DDisposition to issuer Stock Options (right to buy)derivative | -82,644 | - | - | 0 | Apr 27, 2026 |
| Apr 27, 2026 | FOLD AMICUS THERAPEUTICS, INC. | DDisposition to issuer Stock Options (right to buy)derivative | -107,575 | - | - | 0 | Apr 27, 2026 |
| Apr 27, 2026 | FOLD AMICUS THERAPEUTICS, INC. | DDisposition to issuer Stock Options (right to buy)derivative | -108,266 | - | - | 0 | Apr 27, 2026 |
| Apr 27, 2026 | FOLD AMICUS THERAPEUTICS, INC. | DDisposition to issuer Stock Options (right to buy)derivative | -125,462 | - | - | 0 | Apr 27, 2026 |
| Apr 27, 2026 | FOLD AMICUS THERAPEUTICS, INC. | DDisposition to issuer Stock Options (right to buy)derivative | -99,073 | - | - | 0 | Apr 27, 2026 |
| Apr 27, 2026 | FOLD AMICUS THERAPEUTICS, INC. | DDisposition to issuer Stock Options (right to buy)derivative | -150,517 | - | - | 0 | Apr 27, 2026 |
| Jan 2, 2026 | FOLD AMICUS THERAPEUTICS, INC. | FTax withholding Common Stock | -6,905 | $14.27 | $99k | 432,413 | Jan 6, 2026 |
| Jan 3, 2026 | FOLD AMICUS THERAPEUTICS, INC. | FTax withholding Common Stock | -23,102 | $14.27 | $330k | 409,311 | Jan 6, 2026 |
| Nov 24, 2025 | FOLD AMICUS THERAPEUTICS, INC. | MOption exercise Common Stock10b5-1 | +50,000 | $9.03 | $452k | 515,476 | Nov 26, 2025 |
| Nov 24, 2025 | FOLD AMICUS THERAPEUTICS, INC. | SOpen-market sale Common Stock10b5-1 | -76,158 | $10.16 | $774k | 439,318 | Nov 26, 2025 |
| Nov 24, 2025 | FOLD AMICUS THERAPEUTICS, INC. | MOption exercise Stock Options (right to buy)derivative10b5-1 | -50,000 | $0.00 | $0 | 0 | Nov 26, 2025 |
| Feb 11, 2025 | FOLD AMICUS THERAPEUTICS, INC. | AGrant or award Common Stock | +52,338 | $0.00 | $0 | 488,200 | Feb 13, 2025 |
| Feb 11, 2025 | FOLD AMICUS THERAPEUTICS, INC. | FTax withholding Common Stock | -22,724 | $9.57 | $217k | 465,476 | Feb 13, 2025 |
| Jan 2, 2025 | FOLD AMICUS THERAPEUTICS, INC. | FTax withholding Common Stock | -6,990 | $9.31 | $65k | 370,215 | Jan 6, 2025 |
| Jan 3, 2025 | FOLD AMICUS THERAPEUTICS, INC. | AGrant or award Common Stock | +83,073 | $0.00 | $0 | 453,288 | Jan 6, 2025 |
| Jan 3, 2025 | FOLD AMICUS THERAPEUTICS, INC. | FTax withholding Common Stock | -14,299 | $9.41 | $135k | 438,989 | Jan 6, 2025 |
| Jan 4, 2025 | FOLD AMICUS THERAPEUTICS, INC. | FTax withholding Common Stock | -3,127 | $9.41 | $29k | 435,862 | Jan 6, 2025 |
| Jan 3, 2025 | FOLD AMICUS THERAPEUTICS, INC. | AGrant or award Stock Options (right to buy)derivative | +150,517 | $0.00 | $0 | 150,517 | Jan 6, 2025 |
| Dec 28, 2023 | FOLD AMICUS THERAPEUTICS, INC. | SOpen-market sale Common Stock10b5-1 | -17,421 | $14.52 | $253k | 340,661 | Dec 29, 2023 |
| Dec 18, 2023 | FOLD AMICUS THERAPEUTICS, INC. | AGrant or award Common Stock10b5-1 | +8,643 | $0.00 | $0 | 377,236 | Dec 20, 2023 |
| Dec 19, 2023 | FOLD AMICUS THERAPEUTICS, INC. | SOpen-market sale Common Stock10b5-1 | -17,500 | $13.25 | $232k | 359,736 | Dec 20, 2023 |
| Dec 20, 2023 | FOLD AMICUS THERAPEUTICS, INC. | SOpen-market sale Common Stock10b5-1 | -1,654 | $13.10 | $22k | 358,082 | Dec 20, 2023 |
Questions about Jeff Castelli
Answered from the filings on this page, as of the latest one.
Is Jeff Castelli buying or selling?
In the last 12 months Jeff Castelli reported 0 open-market buys worth $0 and 1 open-market sell worth $774k on SEC Form 4; the latest was sold $774k of FOLD on Nov 24, 2025. Grants, option exercises and tax withholding are not counted.
How did Jeff Castelli's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Jeff Castelli has 0.
Where does Jeff Castelli file Form 4?
Jeff Castelli has filed Form 4 at FOLD (AMICUS THERAPEUTICS, INC.) as Chief Development Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.